Pfizer Mergers & Acquisitions

Pfizer M&A Summary

Pfizer has acquired 52 companies, including 12 in the last 5 years. A total of 14 acquisitions came from private equity firms. It has also divested 19 assets.

Pfizer’s largest acquisition to date was in 2000, when it acquired Warner-Lambert Company for $90.2B. It’s largest disclosed sale occurred in 2006, when it sold Pfizer Consumer Healthcare to Johnson & Johnson for $16.6B. Pfizer has acquired in 14 different US states, and 8 countries. The Company’s most targeted sectors include life science (90%) and consumer products (5%).

M&A Summary

  • M&A Total Activity64
    • M&A Buy Activity45
    • M&A Sell Activity19
  • Total Sectors Invested 4
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 32

Pfizer

Pfizer, Inc.

66 Hudson Boulevard East,
New York, New York 10001
United States,
(212) 733-2323
www.pfizer.com

All (64) Buy (45) Sell (19)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-09-22 Metsera · Life Science
New York, New York · www.metsera.com

Metsera is a clinical-stage biopharmaceutical company accelerating medicines for obesity and metabolic diseases. The company is advancing a broad portfolio of oral and injectable incretin, non-incretin, and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Metsera was founded in 2022 and is based in New York City.

Advisors: Allen & Company , BofA Securities , Goldman Sachs , Guggenheim Securities , Paul, Weiss, Rifkind, Wharton & Garrison
4,900 Add-on Acquisition

Pfizer
Advisors: Citi , Wachtell, Lipton, Rosen & Katz

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.